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ABSTRACT: Gas chromatography was used to study the cannabinoid content (‘‘potency’’) of illicit cannabis seized by police in England in
2004 ⁄5. Of the four hundred and fifty two samples, indoor-grown unpollinated female cannabis (‘‘sinsemilla’’) was the most frequent form, followed
by resin (hashish) and imported outdoor-grown herbal cannabis (marijuana). The content of the psychoactive cannabinoid D9-tetrahydrocannabinol
(THC) varied widely. The median THC content of herbal cannabis and resin was 2.1% and 3.5%, respectively. The median 13.9% THC content of
sinsemilla was significantly higher than that recorded in the UK in 1996 ⁄8. In sinsemilla and imported herbal cannabis, the content of the antipsy-
chotic cannabinoid cannabidiol (CBD) was extremely low. In resin, however, the average CBD content exceeded that of THC, and the relative pro-
portions of the two cannabinoids varied widely between samples. The increases in average THC content and relative popularity of sinsemilla
cannabis, combined with the absence of the anti-psychotic cannabinoid CBD, suggest that the current trends in cannabis use pose an increasing risk
to those users susceptible to the harmful psychological effects associated with high doses of THC.
KEYWORDS: forensic science, herbal cannabis, marijuana, sinsemilla, resin, hashish, skunk, potency, cannabinoid, D9-tetrahydrocannabi-
nol, cannabidiol, cannabinol
Cannabis is the most frequently used illicit drug in the UK (1).
Of the 109410 drug seizures in England and Wales in 2003, 72%
were of cannabis (2). The material is primarily used for recreational
purposes, but is also employed illegally to treat the symptoms of
multiple sclerosis and a wide range of other medical conditions,
especially those requiring pain-relief (3,4). The drug is prepared
from the plant Cannabis sativa L., the principle active ingredients
being the cannabinoids. This group of at least sixty terpenophenolic
compounds is unique to cannabis. Within the plant these com-
pounds exist as cannabinoid acids (e.g., cannabidiolic acid
[CBDA]), but as the plant material ages or is heated the acids
decarboxylate into the neutral forms (e.g., CBDA ﬁ CBD) (5).
This article refers to each cannabinoid by its neutral form.
Tetrahydrocannabinol is the main psychoactive ingredient in can-
nabis and, according to the British Medical Association (6), this
cannabinoid is also responsible for many other pharmacological
properties of cannabis. However, other cannabinoids have also
demonstrated a range of pharmacological activities (7). CBD has
pharmacological properties but is not psychoactive. Based on pre-
clinical and clinical data, CBD is notable for its ability to antago-
nize the psychoactive effect of THC (8–11). Its presence would be
suspected of lowering the recreational value of cannabis.
A number of studies have reported that those who consistently
consume large amounts of cannabis have an increased risk of later
developing schizophrenia-like psychoses (12,13). Consumers using
cannabis lacking the antipsychotic cannabinoid CBD may have
been at greater risk. Smith (14) highlighted that high potency can-
nabis products lacking CBD have the potential to be more harmful,
and suggested that more research was required to investigate how
cannabis type or variety affects clinical disorders. Recognizing this
same fact, the United Nations Office on Drugs and Crime 2006
World Drug Report stated that where possible it would be advis-
able to track both THC and CBD levels in future evaluations of
‘‘potency’’ (15). This is believed to be the first large-scale UK
study to do so.
Within the UK the illicit drug commonly exists as either a resin
(more commonly known as hashish in the USA) or a dried-plant
preparation. Within the latter category there are two distinct types
of material circulating. One form is imported into the UK, from a
number of tropical or subtropical countries, and contains floral and
foliar material from outdoor grown pollinated female plants. This
type is commonly referred to as herbal cannabis in the UK and as
marijuana in the USA. The more frequent type of dried-plant mate-
rial in the UK is referred to in this note using the internationally
recognized term sinsemilla (Spanish derivation meaning without
seeds). This form is predominantly grown indoors using all-female
plants and highly technical equipment. Sinsemilla is more typically
referred to as skunk in the UK. Many publications on cannabis,
including official UK Home Office reports (2), do not differentiate
between these two forms of cannabis dried-plant material. In such
cases they are both commonly referred to as herbal cannabis.
Previous studies have shown that the content of THC and other
major cannabinoids varies widely in illicit cannabis (16). Evidence
also suggests that the average potency of the material in the UK
has risen steadily in recent years (17). The aim of this study was to
determine the relative popularity and cannabinoid content of the
different forms of illicit cannabis, enabling assessment of both their
differing medicinal efficacy and potential harm. This was achieved
by analysing the cannabinoid content of four hundred and fifty two
samples, seized during 2004 ⁄5 by police constabularies in five
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geographically spread localities. These areas covered communities
with a range of socio-economic and racial mixes and varying
opportunities for illegal import through nearby ports.
Methods
Acquisition and Identification of Samples
Samples were collected from the police property stores of five
constabularies – Derbyshire, Kent, London Metropolitan, Mersey-
side and Sussex. All samples were collected during a range of dates
in 2005, some of which had been stored at room temperature for
up to a year.3 The majority of the materials had been seized from
users and suppliers ‘‘on the street.’’ The remainder were found dur-
ing searches of property suspected of being involved in cannabis
production or consumption.
The materials were assessed visually, using a simple light micro-
scope where necessary, and the form of the cannabis sample was
established. Four categories were identified:
Cannabis Resin (Hashish)— This consists of the glandular tric-
homes and other fine particles collected from the inflorescences
and upper leaves and bracts. The material is compressed into hard
blocks prior to importation. All samples were dark brown in color.
These samples varied in shape and size and, when present in suffi-
cient quantity, these generally had a light characteristic odor.
Herbal Cannabis (Marijuana)— As adopted by King et al.
(17), this category included imported dried plant material collected
from plants grown outdoors. The material was light to dark brown
in color. The glandular trichomes were always brown in color
because of aging (18). Seeds were frequently present. The material
was sometimes in loose form, but was also frequently encountered
in hard blocks where it had been compressed to reduce volume
during importation. The material had a light fragrant odor. Fungal
mycelium was occasionally visible, suggesting that decay had
occurred at some point during importation or storage.
Sinsemilla (Skunk)— This form of cannabis was light green or
gray-green in color. The material consisted of resinous female floral
material only. Close examination often revealed where bracts and
leaves had been physically removed. Large intact sections of inflo-
rescence, up to several grams in weight, were sometimes present.
More commonly, the material had been loosely ground in prepara-
tion for smoking. Seeds were always absent as a result of the all-
female crops being grown in the absence of pollen. Glandular tri-
chome color varied between crystal clear, white, and light brown.
The odor was clearly stronger than that of resin and herbal canna-
bis. There was no visible sign of fungal deterioration. This pungent,
light material is generally regarded as having been grown in the
UK, but some will possibly have entered the UK from mainland
Europe.
Cannabis Powder— Some herbal cannabis and sinsemilla sam-
ples were recovered from portable cannabis grinders, that are used to
break herbal cannabis and sinsemilla into a suitably fine texture for
smoking. More complex grinders included a fine metal mesh within
the construction. Glandular trichomes dislodged from the plant dur-
ing grinding could fall through this sieve and be collected in a sepa-
rate chamber within the device. Glandular trichomes are the
principal or sole site of cannabinoid biosynthesis (19). One grinder
was found with c. 1 cm)3 of separated yellow powder. This con-
sisted almost entirely of glandular trichome resin heads and stalks.
Previous studies on illicit cannabis potency in the UK have
included analyses of hash oil. This liquid preparation is made by
dissolving, and subsequently concentrating, cannabis extracts in an
organic solvent (20,21). No such samples were identified during
this study.
Many samples were seized which consisted of a mixture of can-
nabis and tobacco. All were excluded from this study. Three seized
suspected-cannabis samples were also analyzed and found to be
plant material other than cannabis or tobacco.
Chromatographic Analysis
The analysis method used in this study was that developed by
de Meijer et al. (5) for the validated identification and quantifica-
tion of a range of cannabinoids.
Statistical Analysis
Analyses of variance were performed to test the significance of
the differing potencies of samples between constabularies.
The Kolgomorov–Smirnov test was used to compare the distribu-
tions of sinsemilla potencies between those found in this study in
2005 and that reported for 1996 ⁄8 by King et al. (17). The change
in average potency was assessed using the Wilcoxon rank-sum test
and the Hodges-Lehmann estimator used to estimate the size of the
difference.
Results and Discussion
Pattern of Distribution of Sinsemilla, Herbal Cannabis and
Resin Across the Regions
Sinsemilla was the most common form found overall, accounting
for 55% of the samples seized. However, differences were found
between regions. In Kent, resin accounted for 85 of the 143 samples
(59%), possibly because of importation through the major ports in
this region. Herbal cannabis is presently the most common form of
cannabis in the USA (15). In contrast, this study reveals that this
type is the least common in the UK. Little or no herbal cannabis
was identified in four of the regions, but it accounted for 30 of the
158 samples (19%) seized in the London Metropolitan area.
Comparison of Potency Levels of Cannabis Resin and Sinse-
milla Between Regions
There were large differences in the mean potencies of resin
between regions. Resin seized in Sussex (6.6%) and Derbyshire
(5.4%) had significantly higher mean THC content (p < 0.05) than
that seized in Kent (4.2%), London (3.6%) or Merseyside (2.8%).
Without knowledge of the sources of the resin in each area it is
not possible to explain why these differences existed, or if they are
consistent.
There were proportionally smaller but statistically significant dif-
ferences in mean THC content of sinsemilla seized in different
areas. The highest mean THC content was found in the Derbyshire
region (16.3%). This material was significantly more potent
(p < 0.05%) than that seized in London (mean 12.9%). The
remaining counties returned mean sinsemilla potencies values
between these two extremes, the differences in potency not being
statistically significant (p = 0.05). Because of the small number or
absence of herbal cannabis samples in most regions, a meaningful
comparison of herbal cannabis potency levels between regions was
not possible.
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The Pattern and Range of Potencies of Resin, Herbal Cannabis
and Sinsemilla
The potency of resin samples varied widely from almost 0%
THC up to nearly 11% (Table 1). The majority of the samples
were at the weaker end of this range. 40% had a THC content of
<2% THC, and more than 80% had <6%. The range of potencies
in herbal cannabis was similar. The maximum THC content found
was nearly 12% but approximately 90% had a content of <6%.
Sinsemilla potency ranged from about 1% to 23%, the the
majority being toward the high end of this range.
Comparison of the Variation in Cannabinoid Profiles of Canna-
bis Samples
The range of potencies of a number of cannabinoids, including
THC, in resin, herbal cannabis, sinsemilla and cannabis powder is
shown in Table 1.
The range of cannabinoids (the cannabinoid profile) in most
samples of sinsemilla showed minimal presence of cannabinoids
other than THC. The tetrahydrocannabivarin (THCV), cannabigerol
(CBG), and CBN content4 occasionally exceeded 2%, but this was
approximately one-tenth of the maximum potency recorded for
THC. The CBD content of sinsemilla was typically very low and
fell below detectable levels (0.1%) in the majority of samples.
THC was also the dominant cannabinoid in herbal cannabis and
CBD levels were mostly below the detectable threshold (0.1%). In
both sinsemilla and herbal cannabis, the THC content was typically
an order of magnitude greater than that of CBC, THCV, or CBG.
CBN levels were much higher in herbal cannabis than in sinsemilla.
This is at least partly because of the length of time that herbal canna-
bis encounters on its route to the UK. A long transport period would
favor the breakdown of THC to the catabolite CBN (22).
Cannabis resin had a very different cannabinoid profile to herbal
cannabis and sinsemilla. CBD was the dominant cannabinoid in
this material, with average THC contents being marginally less.
CBN was present in much higher quantities than in herbal cannabis
or sinsemilla. These contrasting cannabinoid ratios are very similar
to those found in US cannabis samples by ElSohly et al. (12)5
between 1980 and 1997.
Research suggests that the production of THC or CBD, from the
common precursor CBG, is closely controlled by two co-dominant
alleles at a single locus (5). As a result, cannabis plants can be
identified as belonging to any one of three chemotypes. These can
be THC dominant, CBD dominant or containing an approximately
equal mixture of the two (5,23,24). The majority of the cannabis
resin would appear to be prepared from landrace populations of
plants which contain all three chemotypes. Herbal cannabis and sin-
semilla appear almost entirely derived from the THC dominant
chemotype.
Cannabis resin samples showed very variable contents of THC
(0.44–10.76%) and CBD (0.36–6.97%). The ratio of these cannabi-
noids within individual samples varied widely. As CBD is reported
to attenuate the psychoactive effects of THC, the wide range of
THC:CBD ratios would be expected to variably alter the potential
psychoactive and pharmacological effects of the THC within the
resin. This emphasizes that the potential psychoactive and pharma-
cological properties of cannabis resin should not be simply judged
by the THC content alone. The remarkably uniform appearance of
the resin samples gave no indication of the variable cannabinoid
content and profile.
The cannabis powder, retrieved from the herb grinder was the
most potent of the samples analyzed (40.6% THC) (Table 1). This
material had been prepared using a very simple piece of equipment,
and this illustrates that extremely potent cannabis preparations are
readily available.
Increasing Potency Levels
The mean THC content of imported herbal cannabis in this
study (3.1%) was lower than the 4–5% observed by the UK
Forensic Service between 1995 and 1999 (15). Little inference
regarding potency trends can be drawn from this because of the
small number of samples in both studies. The mean THC content
of resin (3.7%) was typical of that found previously, where
potency levels varied from approximately 3–6% THC between
1998 and 2002.
As stated earlier, CBN is the major breakdown product of THC,
the conversion of THC to CBN being accelerated in hot, damp,
and or bright conditions (22). The low median CBN content in sin-
semilla cannabis suggests that the storage conditions in the police
facilities satisfactorily maintained the stability of the cannabis sam-
ples. The higher levels of CBN in herbal cannabis and cannabis
resin was therefore probably not attributable to conditions in police
storage, and was most likely attributable to unfavorable conditions
during outdoor propagation, storage, manufacture, and
transportation.
The mean sinsemilla potency of 13.3% is higher than that
reported by the Forensic Science Service over the period 1995 to
2003 (17). During this period the reported mean THC content rose
from approximately 6.0–12.5%. This supports the belief that sinse-
milla potency in the UK is increasing, although at nothing like the
rate observed in the mid to late Nineties.
In both this study and that performed by the Forensic Science
Service the THC content of samples ranged from <2% THC to
>20%. The range of sinsemilla potency levels observed in each
study is compared directly in Fig. 1.
The data in Fig. 1 was analyzed using the Kolmogorov–Smirnov
test for different distributions. This showed that the two distribution
curves were significantly different (p < 0.0001). A Wilcoxon Rank
Sum test showed that the potency levels in 2005 were significantly
higher than those in 1996 ⁄8 (p < 0.0001). A Hodges-Lehman Esti-
mate of median difference suggests an increase of 4.86% THC in
the median potency between the 1996 ⁄8 data and the 2005 data
(CI = 3.77, 5.54).
TABLE 1—The median and the range of potencies of cannabinoids (%
w ⁄w) in resin (n = 169), herbal cannabis (n = 35), sinsemilla (n = 247) and
cannabis powder (n = 1), seized in five constabularies in England in 2004 ⁄ 5
(total n = 452).9
Type THC CBD CBC THCV CBG CBN
Resin
Median 3.54 4.17 0.34 0.10 0.29 1.55
Minimum 0.44 0.36 <0.10 <0.10 <0.10 0.38
Maximum 10.76 6.97 0.66 0.29 1.05 4.30
Herbal
Median 2.14 <0.10 0.22 0.17 0.21 0.55
Minimum 0.28 <0.10 <0.10 <0.10 <0.10 <0.10
Maximum 11.81 1.97 0.42 0.43 0.76 3.62
Sinsemilla
Median 13.98 <0.10 0.20 <0.03 0.41 0.16
Minimum 1.15 <0.10 <0.10 <0.10 <0.10 <0.10
Maximum 23.17 0.56 1.41 2.74 2.16 2.98
Powder 40.63 0.18 0.41 0.29 1.59 0.57
The cannabinoids studied, in addition to THC, CBD and CBN, were
CBC (cannabichromene), THCV (tetrahydrocannabivarin) and CBG
(cannabigerol).
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Large increases in cannabis potency achieved in 1970s were lar-
gely attributed to the achievements of cannabis breeders (25). Many
cultivars produced in the 1970s and 1980s are still widely used.
Although seeds of new cannabis cultivars are continually produced
in large numbers (26) these do not appear to produce plants of sig-
nificantly higher THC content (Potter, unpublished data). The rise
in reported potency is more likely due to increasing expertise
amongst the illicit UK growers in recent years. During this period
there has been a large increase in the number of retail outlets sell-
ing cannabis seeds and sophisticated growing equipment. Many
books, videos, and DVDs have been produced, educating growers
how to maximize cannabis potency. The internet has facilitated on-
line purchasing of these items. Expert web pages and focused
‘‘chat-rooms’’ have provided easily accessible advice. During this
period, the UK Government and Police express the opinion that the
production and dealing of cannabis have not always been targeted
sufficiently vigorously (27).
Conclusions
This study suggests that cannabis in England in 2005 remains a
very variable drug with unpredictable pharmacological and psycho-
logical activity. The potency (THC content) of the cannabis varies
widely, as does the content of other cannabinoids, especially in her-
bal cannabis and cannabis resin. The average potency within the
country appears to be increasing, but large variations remain within
and between different areas of the country.
CBD affects the pharmacological qualities of THC and reduces
it psychoactive potential. The relative proportions of THC and
CBD in resin are wide ranging, supporting the view that the
potential effects of resin cannot be judged by measuring the
THC content alone. The resin samples were all similar in appear-
ance and gave the user no indication of their cannabinoid
content.
Of the three principle forms of cannabis, sinsemilla commonly
had the highest THC content and almost totally lacked CBD. Had
CBD been present it would have reduced the psychoactive potential
of this material. In addition to increase in potency, sinsemilla also
appears to become the most widely used form of cannabis. The
current trends in cannabis use suggest that those susceptible to the
harmful psychological effects associated with THC are at ever
greater risk. This is due to the rise in popularity of sinsemilla,
which has increased in potency and lacks the antipsychotic cannab-
inoid CBD.
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Manual of Style and visit them on the Web at: http://www.chicagomanualofstyle.org/home.
html
Instruction to printer
Leave unchanged under matter to remain
through single character, rule or underline
New matter followed by
or
or
ornew character
new characters
through all characters to be deleted
through letter   or
through characters
under matter to be changed
under matter to be changed
under matter to be changed
under matter to be changed
under matter to be changed
Encircle matter to be changed
or
indicated in the margin
Delete
Substitute character or
substitute part of one or
more word(s)
Change to italics
Change to capitals
Change to small capitals
Change to bold type
Change to bold italic
Change to lower case
Insert in text the matter
Textual mark Marginal mark
followed by ne  
matter
through single character, rule or underline
through all characters to be dele ed
B
or
ore.g.
under character
over character(As above)
through character    or
where required
Insert ‘superior’ character
Insert ‘inferior’ character
struction to typesetter
superscript
Insert subscript
 under character
e.g.
 over character
e.g.
(As above)
(As above)
Insert full stop
Insert comma
linking characters
through character    or
where required
Transpose
Close up
Insert or substitute space
between characters or words
or
or
and/or(As above)Insert double quotation marks
(As above)Insert single quotation marks
(As above)Insert hyphen
Start new paragraph
between characters or
words affected
Reduce space between
characters or words
t r  si l  r t , r l  r rli
through all ch r cters to b  deleted
f llow d by new 
